Concepedia

Danica Ramljak

DR

Statistics

Publications

11

Citations

477

H-Index

11

Active since

1996

Affiliations

National Cancer Institute(Current)

Science Applications International Corporation (United States)

Frederick National Laboratory for Cancer Research

Georgetown University

Georgetown University Medical Center

Danica Ramljak is an author at National Cancer Institute specializing in oncology, carcinogenesis, and liver disease.

Publications per year

1996–2005

11

Publications

11

Pentameric procyanidin from <i>Theobroma cacao</i> selectively inhibits growth of human breast cancer cells

Danica Ramljak, Leo J. Romanczyk, Linda J. Metheny‐Barlow et al. · Molecular Cancer Therapeutics · 2005 · 94 citations

Medicine, Oncology, Pharmacology +13

Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCδ-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation

Ivana Vučenik, Gayatri Ramakrishna, Kwanchanit Tantivejkul et al. · Breast Cancer Research and Treatment · 2005 · 88 citations

Life Sciences, Molecular Biology, Oncology +13

A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity

Danica Ramljak, Richard J. Calvert, Paddy Wiesenfeld et al. · Carcinogenesis · 2000 · 60 citations · Full text

Pharmacy, Biochemistry, Oncology +17

Promotion by Helicobacter hepaticus-Induced Hepatitis of Hepatic Tumors Initiated by N-Nitrosodimethylamine in Male A/JCr Mice

Bhalchandra A. Diwan, Jerrold M. Ward, Danica Ramljak et al. · Toxicologic Pathology · 1997 · 53 citations

Medicine, Oncology, Pathobiology +11

Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells

Danica Ramljak · Experimental Cell Research · 2003 · 38 citations

Life Sciences, Cell Biology, Oncology +17

1–5 of 11